CODAGENIC ECOMMERCE
Codagenic is a software development group based in Melbourne, Australia. We design and develop premium, user-centric Web applications for demanding environments. Codagenic eCommerce is everything you need to run your online store, featuring out-of-the-box mobile and tablet optimisation, multi-site management, product search, bulk import, the ability to integrate with ERP and CRM systems and tablet-friendly administration. Built on robust Microsoft ASP.Net technology, Codagenic eCommerce is y... our engine for online sales growth. Our software is designed to be flexible and powerful, giving retail brands full control over how their website looks and works, whilst providing all the tools most retailers need out-of-the-box. Codagenic is an agile software development business based in Melbourne, Australia with a team of talented developers, UX designers, product, ecommerce and retail experts working together to build functional, useful and usable ecommerce software.
CODAGENIC ECOMMERCE
Industry:
E-Commerce Information Technology Software
Founded:
1998-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.codagenic.com
Total Employee:
51+
Status:
Active
Contact:
+61 3 9415 2333
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Amazon Virginia Region Amazon Ohio Region NameBright Amazon ELB Ohio
Official Site Inspections
http://www.codagenic.com
- Host name: ec2-34-205-242-146.compute-1.amazonaws.com
- IP address: 34.205.242.146
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Codagenic eCommerce"
Codagenix - Crunchbase Company Profile & Funding
Codagenix is a developer of live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus. Its vaccines utilize Synthetic Attenuated Virus Engineering …See details»
Codagenix Company Profile 2024: Valuation, Funding & Investors
Codagenix General Information Description. Developer of live-attenuated viral vaccine design technology designed to provide target antigens placed in an attenuated backbone virus. The company's vaccines use synthetic attenuated virus engineering, which is based on synthetic biology and is re-designed for the entire genome to yield a vaccine ...See details»
Team. Building the viralplatform of the future. | Codagenix
The Codagenix team and its founders pioneered the use of codon deoptimization to construct groundbreaking vaccines and virotheraputics. We are now pushing this proven method into the …See details»
Codagenix Announces Appointment of Paul Grint, MD, as …
“I am honored to join Codagenix at such a pivotal time, as the organization leverages its impressive synthetic biology-based platform to pioneer a new era of live-attenuated vaccines and immuno-oncology therapies,” said Dr. Grint “I look forward to partnering with this talented Board and management team to take on the biggest threats in infectious disease and cancer.”See details»
Codagenix - Org Chart, Teams, Culture & Jobs - The Org
View Codagenix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
CODAGENIX - Overview, News & Similar companies | ZoomInfo.com
Who is CODAGENIX. Codagenix is a clinical-stage biotechnology company committed to building the world's most agile, adaptable, and powerful vaccine platform, protect ing us from threats …See details»
Codagenix Inc. - LinkedIn
Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development.See details»
Codagenix - Golden
Organization. Company attributes. Industry. Consumer biotechnology. Engineering. Technology. ... Codagenix is a privately held, biotechnology company based in Stony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE.See details»
Codagenix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 Grint said there is a $6 billion market for COVID-19 vaccines, and Codagenix secured a potential $389 million deal with BARDA in October of last year as well as working …See details»
Codagenix Announces Appointment of Kimber Poffenberger, …
Farmingdale, N.Y., March 28, 2023 – Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for live-attenuated viral vaccines and immuno-oncology therapeutics, today announced that Kimber Poffenberger, Ph.D., has been appointed Chief Strategy Officer. “We are excited to welcome Kimber to Codagenix. With her distinguished …See details»
Codagenix - Contacts, Employees, Board Members, Advisors
Organization. Codagenix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board …See details»
Codagenix Company Profile - Office Locations, Competitors
Codagenix has 5 employees across 2 locations and $49 m in total funding,. See insights on Codagenix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Codagenix CEO and Key Executive Team | Craft.co
Codagenix's Co-Founder is J. Robert Coleman. Other executives include Steffen Mueller, Co-Founder, President and Chief Scientific Officer, Director; Kimber Poffenberger, Chief Strategy …See details»
Codagenix - Funding, Financials, Valuation & Investors - Crunchbase
Codagenix is funded by 9 investors. U.S. Department of Defense and Serum Institute of India Pvt. Ltd. are the most recent investors. Codagenix has a post-money valuation in the range of …See details»
Codagenix - Updates, News, Events, Signals & Triggers - Crunchbase
Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer : Jan 12, 2022: Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal …See details»
Codagenix Announces BARDA Contract for Project NextGen …
Agreement is part of the U.S. Department of Health and Human Services’ Project NextGen and will provide an initial $10 million and up to $389 million to cover costs for a 10,000-volunteer …See details»
Codagenix - VentureRadar
" Codagenix is a clinical stage synthetic biology company that uses software to recode the genomes of viruses, constructing live-attenuated vaccines or viruses to prevent viral infections …See details»
Codagenix begins Phase 3 Clinical Testing of its COVID-19 Vaccine ...
Farmingdale, N.Y., October 26, 2022 – Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, in …See details»
Codagenix Announces BARDA Contract for Project NextGen …
Oct 3, 2023 Codagenix was founded based on technology developed in the laboratory of National Academy of Science member Dr. Eckard Wimmer at Stony Brook University; is …See details»